Our study showed that in PTC patients without diabetes, higher FSG was positively associated with cancer progression, and hyperglycemia was strongly associated with an increased maximum tumor diameter and extension, which may also be associated with IGF-1-associated insulin resistance and hyperinsulinemia. This evidence concerns the gene IGF1 and hyperinsulinism.